162 related articles for article (PubMed ID: 227585)
1. Prolactin receptors in human breast cancer cells in long-term tissue culture.
Shiu RP
Cancer Res; 1979 Nov; 39(11):4381-6. PubMed ID: 227585
[TBL] [Abstract][Full Text] [Related]
2. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
[TBL] [Abstract][Full Text] [Related]
3. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.
Biswas R; Vonderhaar BK
Cancer Res; 1987 Jul; 47(13):3509-14. PubMed ID: 3581086
[TBL] [Abstract][Full Text] [Related]
4. Hormone binding by human mammary carcinoma.
Holdaway IM; Friesen HG
Cancer Res; 1977 Jul; 37(7 Pt 1):1946-52. PubMed ID: 193630
[TBL] [Abstract][Full Text] [Related]
5. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).
Leroy-Martin B; Peyrat JP
Anticancer Res; 1989; 9(3):631-6. PubMed ID: 2764510
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture.
Imai Y; Leung CK; Friesen HG; Shiu RP
Cancer Res; 1982 Nov; 42(11):4394-8. PubMed ID: 6290036
[TBL] [Abstract][Full Text] [Related]
7. Effect of prolactin on lactalbumin production by normal and malignant human breast tissue in organ culture.
Wilson GD; Woods KL; Walker RA; Howell A
Cancer Res; 1980 Feb; 40(2):486-9. PubMed ID: 6243254
[TBL] [Abstract][Full Text] [Related]
8. Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells.
Sapi E; Flick MB; Rodov S; Carter D; Kacinski BM
J Soc Gynecol Investig; 1998; 5(2):94-101. PubMed ID: 9509388
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of prolactin binding by cyclosporine A on MCF7 breast tumour cell line.
Bernard DJ; Maurizis JC; Sauvezie B; Bignon YJ; Chassagne J; Chollet P; Plagne R
Anticancer Res; 1991; 11(6):2147-51. PubMed ID: 1776854
[TBL] [Abstract][Full Text] [Related]
10. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone.
Shiu RP; Paterson JA
Cancer Res; 1984 Mar; 44(3):1178-86. PubMed ID: 6692402
[TBL] [Abstract][Full Text] [Related]
11. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).
Briand P
Anticancer Res; 1983; 3(4):273-81. PubMed ID: 6309070
[TBL] [Abstract][Full Text] [Related]
12. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
Fitzpatrick SL; LaChance MP; Schultz GS
Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
[TBL] [Abstract][Full Text] [Related]
13. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
14. Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment.
Ben-David M; Kadar T; Wittliff J; Biran S; Schally A
Biomed Pharmacother; 1988; 42(2):101-9. PubMed ID: 3167163
[TBL] [Abstract][Full Text] [Related]
15. Prolactin receptors in human breast tumors.
Turcot-Lemay L; Kelly PA
J Natl Cancer Inst; 1982 Mar; 68(3):381-3. PubMed ID: 6278192
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of prolactin receptors in human breast cancer.
Ben-David M; Dror Y; Biran S
Isr J Med Sci; 1981; 17(9-10):965-9. PubMed ID: 6273360
[TBL] [Abstract][Full Text] [Related]
17. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
18. Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma.
Meng J; Tsai-Morris CH; Dufau ML
Cancer Res; 2004 Aug; 64(16):5677-82. PubMed ID: 15313907
[TBL] [Abstract][Full Text] [Related]
19. Tissue immunoreactive prolactin hormone in breast cancer.
Castro A; Buschbaum P; Nadji M; Voigt W; Ziegels-Weissman J; Morales A
Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):159-70. PubMed ID: 6250206
[TBL] [Abstract][Full Text] [Related]
20. Relation between steroid receptor content and the response to hormone addition in isolated human breast cancer cells in short-term culture.
Israel N; Saez S
Cancer Res; 1978 Nov; 38(11 Pt 2):4314-7. PubMed ID: 698973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
